Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical” or "the Company”, "we”, or "our”), a commercial-stage ...

Vice President of Shanghai Pharmaceuticals Li Dongming said on Tuesday that he hopes there will be more investment from ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Onyx Biotec is launching an SME IPO to raise Rs 29 crore by offering shares at Rs 58-61 apiece. The pharmaceutical company ...

To build out the facility and ensure the success of this new venture, QPS has hired Tia Hexom, PhD, (Senior Director of Cell ...

Sanjay Kapote, President of Aptar Pharma India and Southeast Asia said, in the last 10 years, the company had achieved ...

Teknor Apex Co. is expanding its thermoplastic elastomer (TPE) portfolio. The new medical grade products are intended for ...

AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...

Through harnessing innovations in its regulatory processes, including digital transformation in health care, BPOM is ...

As 2024 ushers in political change, one of the most contentious issues bubbling beneath the surface is public health — notably, the role of addictive substances ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Universe Pharmaceuticals INC (NASDAQ: UPC) ("Universe Pharmaceuticals” or the "Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share ...